STOCK TITAN

Haemonetics First Quarter Fiscal 2021 Earnings Release Available on Investor Relations Website

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Haemonetics Corporation (NYSE:HAE) announced its financial results for the first quarter of fiscal 2021, ending June 27, 2020. The detailed earnings release and results tables are now available on their Investor Relations website. The company will host a conference call for investors and analysts on August 4, 2020, at 8 a.m. EDT to discuss the results. Interested parties can access the call using a toll-free number or via a live webcast. For additional information, visit Haemonetics' official website.

Positive
  • None.
Negative
  • None.

BOSTON, Aug. 4, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website.

In addition, the Company is also posting the earnings release and results tables that will be referenced on its webcast. 

Direct link to Earnings Release 1Q FY 21:
https://haemonetics.gcs-web.com/static-files/3ac4ad70-f511-46d1-ba93-a5b042e02b0d

Direct link to Results Tables 1Q FY 21 for reference on webcast conference call:
https://haemonetics.gcs-web.com/static-files/692a68f7-2dd2-429c-8167-2e30a60ab472
 

The Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8 a.m. EDT August 4, 2020. The call can be accessed with the following information:

  • U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
  • Conference ID required for access: 3897757
  • A live webcast of the call can be accessed on Haemonetics' Investor Relations website.
  • Direct link to conference call webcast: https://edge.media-server.com/mmc/p/4ueq6p7x

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our website at http://www.haemonetics.com.          

 

Investor Contact

Media Contact

Olga Guyette, Director-Investor Relations

Carla Burigatto, VP-Communications

(781) 356-9763

(781) 348-7263

olga.guyette@haemonetics.com

carla.burigatto@haemonetics.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-first-quarter-fiscal-2021-earnings-release-available-on-investor-relations-website-301105159.html

SOURCE Haemonetics Corporation

FAQ

What were Haemonetics' earnings results for Q1 FY2021?

Haemonetics has announced the availability of their earnings results for Q1 FY2021, which ended on June 27, 2020.

When is Haemonetics' Q1 FY2021 conference call?

Haemonetics will host their Q1 FY2021 conference call on August 4, 2020, at 8 a.m. EDT.

How can I access Haemonetics' earnings release?

Haemonetics' earnings release and results tables are available on their Investor Relations website.

What is the direct link to Haemonetics' Q1 FY2021 results?

The direct link to the earnings release is https://haemonetics.gcs-web.com/static-files/3ac4ad70-f511-46d1-ba93-a5b042e02b0d.

Haemonetics Corporation

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Stock Data

4.49B
50.22M
0.89%
116%
10.28%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
BOSTON